Univita
MCAS




about us
underwriting
services
claims services
mcas
univita carelink network
contact us
home
The Minnesota Cognitive Acuity Screen (MCAS) was developed and statistically validated by leading scientists and physicians for Univita to help identify early symptoms of dementia, including Alzheimer's Disease. The MCAS is a much-needed tool to bridge the gap between expensive medical evaluations and a physician's best guess.

Accuracy
This fifteen-minute screen correctly identifies cognitively impaired and unimpaired subjects with 98.1% accuracy, i.e. an error rate of only 1.9%. Other tests have error rates of 10% or more. The MCAS is flexible; it can be administered telephonically or face to face, with minimal false positives or false negatives, and without loss of reliability.

In-Depth Testing
25% to 50% of applicants with cognitive impairments are not detected by memory testing alone. The MCAS is does in-depth testing in a variety of areas of cognition, including:

  • Judgement
  • Short-term memory
  • Reasoning, orientation
  • Comprehension
"The MCAS shows improved expected LTC Insurance profitability compared to any other cognitive screen on the basis of claims savings and increased premiums alone (i.e. ignoring expense savings)."

  — From an independent study by Milliman USA, a leading actuarial firm.

home   about us   underwriting services   claims services   mcas   univita carelink network   contact us
©2012 Univita   all rights reserved   (877) 625-5465